Characterization of hepatitis A vaccine Avaxim (Pasteur Merrier): Summing up field clinical trials

Voprosy Virusologii

Volumn 45, Issue 1, 2000, Pages 39-42

  Gorbunov, M A ^a   Noskova, A V ^a   Yelshina, G A ^a   Bektimirov, T A ^a   Pavlova, L I ^a   Aksenov, L A ^a   Ivanov, A A ^a  

^a NONE

Author keywords

Avaxim vaccine; Characteristics; Hepatitis A; Vaccine prevention

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BIOSYNTHESIS; BLOOD; CHILD; HEPATITIS A VIRUS; HUMAN; IMMUNOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; HEPATITIS A VACCINES; HEPATOVIRUS; HUMANS; VIRAL HEPATITIS VACCINES;

EID: 0033629812     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Andre F. E., Hondt D. E., Delem A. D., SaFary A. Clinical Assessment of the Safety and Efficacy of an Inactivated Hepatitis A Vaccine - Rationale and Summary of Findings // Vaccine. - 1992. - P. 160-168.
2. Balcarek K. B., Bagley M. R. et al. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children // J. infect. Dis. - 1995. - Vol. 171. - Suppl. I. - P. S70-S72.
3. Brindle R., Morris C. A., Berger R., Kurtz J. B. Inadequate response to intradermal hepatitis A vaccine // Vaccine. - 1994. - Vol. 12. - P. 483-484.
4. Bryan J. P., Nelson M. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines // Arch. intern. Med. - 1994. - Vol. 154. - P. 663-668.
5. Clemens R., Safary A. Clinical experience with inactivated hepatitis A vaccine // J. infect. Dis. - 1995. - Vol. 171. - Suppl. 1. - P. S44-S49.
6. Findor J. A., Velasco M. C. C. et al. Response to hepatitis A vaccine in children after a single dose with a booster administration 6 months later // J. Travel Med. - 1996. - Vol. 3. - P. 156-159.
7. Garin D., Vidor E., Wallon M. et al. Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults // Vaccine. - 1995. - Vol. 13. - P. 220-224.
8. Goilav C., Zuckerman J., Lafrenz M. et al. Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study // J. med. Virol. - 1995. - Vol. 46. - P. 287-292.
9. Horng Y. C., Chang M. H., Lee C. Y. et al. Safety and immunogenicity of hepatitis A vaccine in healthy children // Pediat. infect. Dis. J. - 1993. - Vol. 12. - P. 359-362.
10. Horng Y. S., Chang M. H., Lee C. Y. et al. Safety and immunogenicity of hepatitis A vaccine in healthy adult volunteers // J. Gastroenterol. Hepatol. - 1993. - Vol. 8. - P. 338-341.
11. Innis B. L., Snitbhan R., Kunasol P. et al. Protection against hepatitis A by an inactivated vaccine // J. A. M. A. - 1994. - Vol. 271. - P. 1328-1334.
12. Lee S. D., Lo K. J., Chan C. Y. et al. Immunogenicity of inactivated hepatitis A vaccine in children // Gastroenterology. - 1993. - Vol. 104. - P. 1129-1132.
13. McMahon B., Beller M. et al. A program to control an outbreak of hepatitis A in Alaska by an inactivated hepatitis A vaccine // Arch. Pediat. Adolesc. Med. - 1996. - Vol. 150. - P. 733-739.
14. Nalin D. R., Brown L., Kuter B. et al. Inactivated hepatitis A vaccine in childhood - implication for disease control // Vaccine. - 1993. - Vol. 11. - P. S15-S17.
15. Poovorawan Y. Changing epidemiology and prevention of hepatitis A virus infection // Chung Hua Min Kuo Hsiao Erh Ko I Hsuch Hui Tsa Cin. - 1998. - Vol. 39, N 3. - P. 139-145.
16. Vidor E., Fanget B. et al. Preliminary results of the clinical development of a highly purified inactivated hepatitis A vaccine // Immunoprophylaxe gegen Hepatitis A / Hrsg. H. Spiess. - Marburg, 1993. - S. 115-116.
17. Werzberger A., Mensch B. et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children // New Engl. J. Med. - 1992. - Vol. 327. - P. 453-457.
18. Zuckerman J., Peyron F., Wallon M. et al. Comparison of two monodose inactivated hepatitis A vaccines // Advances in Therapy. - 1997. - Vol. 14. - P. 116-124.